Tuesday, July 29, 2014 Last update: 10:03 AM
FreshNews.com - All Company Technology News Since 1996

Company Profile for Concert Pharmaceuticals, Inc.

Companies mentioned in this article: Concert Pharmaceuticals, Inc.

-- (BUSINESS WIRE) -- Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel small molecule drugs. This approach starts with approved drugs, advanced clinical candidates or previously studied compounds that have the potential to be improved with deuterium substitution to enhance clinical safety, tolerability and efficacy. The company is developing a broad pipeline targeting CNS disorders, renal disease, inflammation and cancer.

Company:

  Concert Pharmaceuticals, Inc.
 

Headquarters Address:

99 Hayden Avenue
Suite 500
Lexington, MA 02421
 

Main Telephone:

781-860-0045
 

Website:

www.concertpharma.com

 

Ticker:

CNCE(NASDAQ)
 

Type of Organization:

Public
 

Industry:

Biotechnology
 

Key Executives:

CEO: Roger Tung

COO: Nancy Stuart

CFO: Ryan Daws

 

Investor Relations

Contact:

Justine Koenigsberg

Phone:

781-674-5284

Email:

ir@concertpharma.com

 

Public Relations

Contact:

Kathryn Morris

Phone:

845-635-9828

Email:

kathryn@theyatesnetwork.com


Copyright © Business Wire 2014